Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cong-Dat Pham

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2025
Preclinical Fluorescence-Guided Imaging Leveraging Surrounding Sentinel Tumor Microenvironment Identifies High-Risk Premalignant Pancreatic LesionsShilpa Sharma, Xiaoxia Wen, Jianbo Wang, et al.
Frontiers in Physiology|January 26, 2024
Overexpression of ameloblastin in secretory ameloblasts results in demarcated, hypomineralized opacities in enamelYong-Hee Patricia Chun, Chunyan Tan, Omar Villanueva, et al.
Analytical Chemistry|July 6, 2022
Quantification of Phosphonate Drugs by <sup>1</sup>H-<sup>31</sup>P HSQC Shows That Rats Are Better Models of Primate Drug Exposure than MiceYasaman Barekatain, Sunada Khadka, Kristen Harris, et al.
ACS Medicinal Chemistry Letters|July 18, 2020
Bioreducible Phosphonoamidate Pro-drug Inhibitor of Enolase: Proof of Concept StudyVictoria C Yan, Kristine L Yang, Elliot S Ballato, et al.
Cancer & Metabolism|June 26, 2021
Impaired anaplerosis is a major contributor to glycolysis inhibitor toxicity in gliomaSunada Khadka, Kenisha Arthur, Yasaman Barekatain, et al.
Biorxiv : the Preprint Server for Biology|June 8, 2021
Pharmacokinetics of Orally Administered GS-441524 in DogsVictoria C Yan, Cong-Dat Pham, Matthew J Yan, et al.
Biorxiv : the Preprint Server for Biology|January 31, 2024
Enolase inhibitors as therapeutic leads for <i>Naegleria fowleri</i> infectionJillian E Milanes, Victoria C Yan, Cong-Dat Pham, et al.
Pathogens (Basel, Switzerland)|November 25, 2023
Enolase Inhibitors as Early Lead Therapeutics against <i>Trypanosoma brucei</i>Colm P Roster, Danielle LaVigne, Jillian E Milanes, et al.
Plos Pathogens|August 1, 2024
Enolase inhibitors as therapeutic leads for Naegleria fowleri infectionJillian E Milanes, Victoria C Yan, Cong-Dat Pham, et al.
Journal of Medicinal Chemistry|October 17, 2022
Prodrugs of a 1-Hydroxy-2-oxopiperidin-3-yl Phosphonate Enolase Inhibitor for the Treatment of <i>ENO1</i>-Deleted CancersVictoria C Yan, Cong-Dat Pham, Elliot S Ballato, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 25, 2025
Preclinical Fluorescence-Guided Imaging Leveraging Surrounding Sentinel Tumor Microenvironment Identifies High-Risk Premalignant Pancreatic LesionsShilpa Sharma, Xiaoxia Wen, Jianbo Wang, et al.
Frontiers in Physiology|January 26, 2024
Overexpression of ameloblastin in secretory ameloblasts results in demarcated, hypomineralized opacities in enamelYong-Hee Patricia Chun, Chunyan Tan, Omar Villanueva, et al.
Analytical Chemistry|July 6, 2022
Quantification of Phosphonate Drugs by <sup>1</sup>H-<sup>31</sup>P HSQC Shows That Rats Are Better Models of Primate Drug Exposure than MiceYasaman Barekatain, Sunada Khadka, Kristen Harris, et al.
ACS Medicinal Chemistry Letters|July 18, 2020
Bioreducible Phosphonoamidate Pro-drug Inhibitor of Enolase: Proof of Concept StudyVictoria C Yan, Kristine L Yang, Elliot S Ballato, et al.
Cancer & Metabolism|June 26, 2021
Impaired anaplerosis is a major contributor to glycolysis inhibitor toxicity in gliomaSunada Khadka, Kenisha Arthur, Yasaman Barekatain, et al.
Biorxiv : the Preprint Server for Biology|June 8, 2021
Pharmacokinetics of Orally Administered GS-441524 in DogsVictoria C Yan, Cong-Dat Pham, Matthew J Yan, et al.
Biorxiv : the Preprint Server for Biology|January 31, 2024
Enolase inhibitors as therapeutic leads for <i>Naegleria fowleri</i> infectionJillian E Milanes, Victoria C Yan, Cong-Dat Pham, et al.
Pathogens (Basel, Switzerland)|November 25, 2023
Enolase Inhibitors as Early Lead Therapeutics against <i>Trypanosoma brucei</i>Colm P Roster, Danielle LaVigne, Jillian E Milanes, et al.
Plos Pathogens|August 1, 2024
Enolase inhibitors as therapeutic leads for Naegleria fowleri infectionJillian E Milanes, Victoria C Yan, Cong-Dat Pham, et al.
Journal of Medicinal Chemistry|October 17, 2022
Prodrugs of a 1-Hydroxy-2-oxopiperidin-3-yl Phosphonate Enolase Inhibitor for the Treatment of <i>ENO1</i>-Deleted CancersVictoria C Yan, Cong-Dat Pham, Elliot S Ballato, et al.
Pageof 3